Ascelia Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	374	408	281	114	503	1,005
Market Cap Growth	24.82%	45.35%	146.68%	-77.38%	-49.95%	-36.78%
Enterprise Value	325	337	212	76	324	716
Last Close Price	2.95	3.21	2.92	3.37	14.94	29.85
Forward PE	11.57	80.38	-	-	-	-
PB Ratio	3.76	4.10	3.56	1.53	2.78	3.27
P/TBV Ratio	8.83	9.62	12.83	6.59	4.06	4.01
Debt / Equity Ratio	0.01	0.01	0.32	0.01	0.00	0.01
Net Debt / Equity Ratio	-0.49	-0.49	-0.63	-0.28	-0.82	-0.84
Net Debt / EBITDA Ratio	0.66	0.66	0.73	0.19	1.01	1.89
Net Debt / FCF Ratio	0.68	0.68	0.79	0.16	1.19	2.23
Quick Ratio	4.25	4.25	1.31	1.98	4.12	10.65
Current Ratio	4.35	4.35	1.35	2.30	4.29	10.94
Return on Equity (ROE)	-85.48%	-85.48%	-104.43%	-85.65%	-53.70%	-46.30%
Return on Assets (ROA)	-36.77%	-36.77%	-37.35%	-45.59%	-33.44%	-29.27%
Return on Capital Employed (ROCE)	-74.70%	-74.70%	-86.30%	-149.60%	-81.60%	-44.70%
Earnings Yield	-20.37%	-18.70%	-28.52%	-96.07%	-26.09%	-12.53%
FCF Yield	-19.32%	-17.73%	-22.39%	-111.45%	-24.90%	-11.60%
Buyback Yield / Dilution	-110.07%	-110.07%	-60.15%	3.10%	-5.58%	-25.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.